CMPS

Compass Pathways PLC

Price

$14.91

return (12m)

204.33%

p/e

-5.11

p/bv

23.82

DIVIDEND YIELD

0.00%

CMPS price

Compass Pathways

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CMPS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.57%

3 months

19.01%

1 year

204.33%

2 years

101.79%

5 years

-52.46%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CMPS

Valuation

P/E

-5.11

Sector -3.50

Industry -3.50

P/BV

23.82

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-6.47

Sector -214.99

Industry -214.99

EV/EBIT

-6.47

Sector -47.59

Industry -47.59

P/EBITDA

-5.14

Sector -21.41

Industry -21.41

P/EBIT

-5.14

Sector -28.65

Industry -28.65

P/Total Assets

3.99

Sector 1.19

Industry 1.19

P/Net Current Assets

36.19

Sector -11.97

Industry -11.97

P/Working Capital

18.58

Sector -167.95

Industry -167.95

EPS

-2.92

Sector -1.81

Industry -1.81

BVPS

0.63

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-466.31%

Sector -56.04%

Industry -56.04%

ROA

-78.12%

Sector -60.31%

Industry -60.31%

ROIC

-76.15%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.30

Sector 2.89

Industry 2.89

Net Debt / EBITDA

1.52

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

1.52

Sector -8.06

Industry -8.06

Net Debt / Equity

-4.53

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.60

Sector -0.85

Industry -0.85

Equity/Assets

0.17

Sector 0.46

Industry 0.46

Liabilities/Assets

0.83

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

36.09%

Sector -

Industry -

Fundamentals CMPS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CMPS Compass Pathways PLC	$14.91	195.88%	0.00%	-5.11	23.82	-466.31%	0.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.09%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	42.33%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.88%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CMPS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Compass Pathways

Compass Pathways PLC

Average Investor10 user rating

4.0 (1 people)

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

62

Employees

Compass Pathways PLC (United States) is listed on the Nasdaq and has a market capitalization of $2.01 billion, with shareholders equity totaling $84.53 million.

The company employs approximately 62 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Compass Pathways PLC reported $- in revenue, generating net income of $-394.19 million.

Key financial metrics include a P/E ratio of -5.11, a price-to-book (P/B) ratio of 23.82, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CMPS.

Market cap

$2.01 billion

Net worth

$84.53 million

$84,533,000.00

Assets

$504.56 million

$504,561,000.00

Total Shares Outstanding

135.04 million

135,039,000

Average Daily Trading Volume

$3.10 million

$3,098,577.00

Sector

Health Care

Industry

Biotechnology

CMPS

CMPS revenue and profits

Financial Results CMPS

DRAG THE FRAME TO SEE MORE DATA

CMPS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,90% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$224.45 51,94% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 86,25% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,90% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$224.45 51,94% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 86,25% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Compass Pathways (CMPS) today?

A cotação de Compass Pathways (CMPS) hoje está em US$ 14.91, com uma variação de 204.33% em relação ao último ano. A cotação de Compass Pathways (CMPS) iniciou o ano negociando na casa dos US$ 6.90 e hoje está em US$ 14.91. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Compass Pathways (CMPS) e dados de ações do Ibovespa e mercados internacionais.

Quando Compass Pathways (CMPS) paga dividendos?

Compass Pathways (CMPS) não distribuiu dividendos no último ano.

Is Compass Pathways (CMPS) a good investment?

Atualmente, Compass Pathways (CMPS) está cotada a US$ 14.91, com um P/L de -5.11, representando um desvio de -350% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 204.33 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 204.33%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Compass Pathways (CMPS) stock?

Investir em ações de Compass Pathways (CMPS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Compass Pathways (CMPS) yield today?

A rentabilidade de Compass Pathways (CMPS) foi de 8.57% no último mês, 204.33% no último ano e -52.46% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Compass Pathways (CMPS) hoje, o investimento total seria de US$ 1,491.24, com base na cotação atual de US$ 14.91.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 4,538.29
Em 5 anos: US$ 708.94
Em 10 anos: US$ 1,491.24

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CMPS

Compass Pathways PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CMPS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CMPS WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Compass Pathways

Compass Pathways PLC

United States

6 years

2020

62

PROFIT X PRICE CMPS

Financial Results CMPS

CMPS cash flow

Asset, Revenue and Profit Growth - CMPS

CMPS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions